Quiet on the insider front: nobody at ProtoKinetix, Inc. bought or sold PKTX shares on the open market this past year.
Big money check: 1 institutions held PKTX as of Q2 2026, and funds were split between buying and selling. Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | SMITH CLARENCE EDWARD | CEO | Buy | 2,000,000 | $0.01 | $20K | SEC |
| Jun 17, 2024 | SMITH CLARENCE EDWARD | CEO | Buy | 3,100,000 | $0.01 | $31K | SEC |
| Jun 17, 2024 | SMITH CLARENCE EDWARD | CEO | Buy | 3,400,000 | $0.01 | $34K | SEC |
| Apr 15, 2024 | SMITH CLARENCE EDWARD | CEO | Buy | 2,500,000 | $0.01 | $25K | SEC |
| Apr 15, 2024 | SMITH CLARENCE EDWARD | CEO | Buy | 666,667 | $0.02 | $13K | SEC |
| Dec 28, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 7,333,334 | $0.02 | $147K | SEC |
| Oct 27, 2023 | Guzzetta Michael Richard | CFO | Buy | 20,000 | $0.02 | $400 | SEC |
| Aug 30, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 1,500,000 | $0.02 | $30K | SEC |
| Jun 15, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 2,000,000 | $0.02 | $40K | SEC |
| May 24, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 3,750,000 | $0.02 | $75K | SEC |
| Jan 31, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 2,000,000 | $0.02 | $40K | SEC |
| Jan 4, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 78,400 | $0.03 | $2K | SEC |
| Jan 4, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 1,850,000 | $0.02 | $37K | SEC |
| Jan 4, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 100,000 | $0.03 | $3K | SEC |
| Jan 4, 2023 | SMITH CLARENCE EDWARD | CEO | Buy | 65,000 | $0.03 | $2K | SEC |
There were no open-market insider trades in PKTX in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
1 investment managers reported holding PKTX in SEC Form 13F filings for Q2 2026.
No congressional trades in PKTX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).